PerkinElmer announced that its in-vitro diagnostic (IVD) kit able to test newborns for the six most commonly screened lysosomal storage disorders (LSDs) has been approved by the U.S. Food and Drug Administration (FDA). The kit, the first commercialized using mass spectrometry instrumentation in the U.S., can screen for all six of…
newborn screening
Recent Posts
- Pompe disease hasn’t changed my desire to have a friend and be a friend
- Report details damage to sensory nerve cells with Pompe gene therapy in case
- The complexities of deciding to have more children in a rare disease family
- First patient dosed in LOPD gene therapy trial
- Study finds milder heart issues in late-onset Pompe disease